Literature DB >> 31644637

Nodular amelanotic melanoma.

Thadeu Santos Silva1, Luciana Rebouças de Araujo2, Gustavo Baptista de Almeida Faro1, Geise Rezende Paiva3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31644637      PMCID: PMC7007043          DOI: 10.1590/abd1806-4841.20198453

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


× No keyword cloud information.
Dear Editor, Amelanotic melanomas are characterized by absence of pigment.[1] They are an infrequent variant of classically described clinical and pathological subtypes, estimated occur in between 2 and 8% of all cases.[1,2] Amelanotic melanomas may present as erythematous maculae on sun-exposed areas, with epidermal alterations, normochromic dermal plaques, without epidermal changes or papulonodular lesions.[1] The most common form is the nodular variant, but any other clinicopathological form can be found.[2] Dermoscopy may serve as a valuable tool for elucidating the suspicion of this entity.[2] Although structures that suggest the presence of melanin are absent, it is possible to visualize vascular patterns and residual pigmentation that are not visible to the naked eye.[3] The predominant vascular pattern in melanocytic and hypomelanotic melanomas depends on tumor thickness.[2] Diagnosis is also hampered by the absence of well-established criteria.[4] In addition, they do not differ from pigmented melanomas in terms of prognosis or treatment.[1] Male patient, 60 years old, with diagnosis of schizophrenia, presented a tumoral lesion approximately 4cm in diameter, pedunculated, in the lumbar region, with a peritumoral erythematous area (Figure 1). The lesion was excised with 2mm margins. Anatomopathological examination evidenced an extensive area of ulceration, covered by fibrinous exudate. The dermis showed a malignant neoplasm composed of large epithelioid and fusiform cells, forming cohesive and extensively infiltrative blocks and areas of necrosis. The cells exhibited intense hyperchromasia and pleomorphism, with numerous typical and atypical mitotic figures, evident nucleoli and eosinophils, and presence of brownish pigment (Figure 2). Immunohistochemistry was positive for Melan A, S100, SOX10, and HMB45, confirming the diagnosis of malignant melanoma, nodular type, with Breslow thickness 1.5cm and mitotic index of 15 mitoses/mm[2] (Figure 3). Lymphatic, blood, and perineural invasion were not detected. Surgical margins were free, 2.6 mm away from the neoplasia.
Figure 1

Tumoral lesion approximately 4cm in diameter, located on the lower back, with surrounding erythema

Figure 2

Histopathology: Confluence of nests of large, atypical mela nocytes. The cells are irregular in size, shape, and spacing. Many have hyperchromatic and pleomorphic nuclei and pigmented cytoplasm (Hematoxylin & eosin, x100)

Figure 3

Immunohistochemistry: expression of HMB45 (HMB45, x100)

Tumoral lesion approximately 4cm in diameter, located on the lower back, with surrounding erythema Histopathology: Confluence of nests of large, atypical mela nocytes. The cells are irregular in size, shape, and spacing. Many have hyperchromatic and pleomorphic nuclei and pigmented cytoplasm (Hematoxylin & eosin, x100) Immunohistochemistry: expression of HMB45 (HMB45, x100) Pigmentation is one of the guiding criteria for the diagnosis of melanocytic lesions, and lack of pigmentation often makes the diagnosis of amelanotic melanoma challenging.[1,2] In such cases, dermoscopy is important for the evaluation of morphological types of vascular structures.[3] The vascular pattern may not be sufficient, and it is essential to associate the clinical findings and patient’s history.[3] The definitive diagnosis can only be established by histopathology, and immunohistochemistry is often necessary.[2,4] The present report highlights the importance of histopathology and immunohistochemistry for diagnostic elucidation. The lack of defined criteria can delay the suspicion and diagnosis, fundamental to prognosis in this highly aggressive and potentially lethal entity.[4]
  4 in total

1.  Amelanotic melanoma: a detailed morphologic analysis with clinicopathologic correlation of 75 cases.

Authors:  Wang L Cheung; Rishi R Patel; Aimee Leonard; Bahar Firoz; Shane A Meehan
Journal:  J Cutan Pathol       Date:  2011-11-03       Impact factor: 1.587

Review 2.  Clinical and dermoscopic characteristics of amelanotic melanomas that are not of the nodular subtype.

Authors:  N Jaimes; R P Braun; L Thomas; A A Marghoob
Journal:  J Eur Acad Dermatol Venereol       Date:  2011-05-18       Impact factor: 6.166

3.  Comparison of clinicopathologic features and survival of histopathologically amelanotic and pigmented melanomas: a population-based study.

Authors:  Nancy E Thomas; Anne Kricker; Weston T Waxweiler; Patrick M Dillon; Klaus J Busman; Lynn From; Pamela A Groben; Bruce K Armstrong; Hoda Anton-Culver; Stephen B Gruber; Loraine D Marrett; Richard P Gallagher; Roberto Zanetti; Stefano Rosso; Terence Dwyer; Alison Venn; Peter A Kanetsky; Irene Orlow; Susan Paine; David W Ollila; Anne S Reiner; Li Luo; Honglin Hao; Jill S Frank; Colin B Begg; Marianne Berwick
Journal:  JAMA Dermatol       Date:  2014-12       Impact factor: 10.282

4.  Amelanotic metastatic cutaneous melanoma.

Authors:  Marcela Sena Teixeira Mendes; Mariana Carvalho Costa; Ciro Martins Gomes; Lisley Calixto de Araújo; Gustavo Henrique Soares Takano
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.